4.7 Review

Cellular and molecular features of neurogenic skeletal muscle atrophy

Journal

EXPERIMENTAL NEUROLOGY
Volume 331, Issue -, Pages -

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.expneurol.2020.113379

Keywords

Skeletal muscle; Denervation; Neurogenic atrophy; Proteolysis; Ubiquitin ligase; Lysosome

Categories

Funding

  1. National Institute of Arthritis and Musculoskeletal and Skin Diseases
  2. National Institute of Neurological Disorders and Stroke
  3. Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
  4. U.S. Department of Defense

Ask authors/readers for more resources

Neurogenic atrophy refers to the loss of muscle mass and function that results directly from injury or disease of the peripheral nervous system. Individuals with neurogenic atrophy may experience reduced functional status and quality of life and, in some circumstances, reduced survival. Distinct pathological findings on muscle histology can aid in diagnosis of a neurogenic cause for muscle dysfunction, and provide indicators for the chronicity of denervation. Denervation induces pleiotypic responses in skeletal muscle, and the molecular mechanisms underlying neurogenic muscle atrophy appear to share common features with other causes of muscle atrophy, including activation of FOXO transcription factors and corresponding induction of ubiquitin-proteasomal and lysosomal degradation. In this review, we provide an overview of histologic features of neurogenic atrophy and a summary of current understanding of underlying mechanisms.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available